PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $392,000 | -12.9% | 77,915 | +11.3% | 0.05% | +1.9% |
| Q2 2015 | $450,000 | +78.6% | 70,010 | +95.7% | 0.05% | +82.8% |
| Q1 2015 | $252,000 | +66.9% | 35,776 | +83.1% | 0.03% | +81.2% |
| Q4 2014 | $151,000 | -85.7% | 19,537 | -86.2% | 0.02% | -85.2% |
| Q3 2014 | $1,054,000 | -69.4% | 141,081 | -60.4% | 0.11% | -68.6% |
| Q2 2014 | $3,450,000 | +136.8% | 356,359 | +103.3% | 0.34% | +132.4% |
| Q1 2014 | $1,457,000 | +15.8% | 175,291 | +17.6% | 0.15% | +18.4% |
| Q4 2013 | $1,258,000 | +55.9% | 149,101 | +47.2% | 0.12% | +48.8% |
| Q3 2013 | $807,000 | – | 101,293 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |